Prostatic bioregulatory polypeptide prostatilen: pharmacological properties and 30-year experience of clinical application in urology

2020 ◽  
Vol 10 (3) ◽  
pp. 243-258
Author(s):  
Igor V. Kuzmin ◽  
Sergey Yu. Borovets ◽  
Anatoliy G. Gorbachev ◽  
Salman Kh. Al-Shukri
Keyword(s):  
Clinical Application ◽  
Chronic Prostatitis ◽  
Inflammatory Diseases ◽  
Experimental Studies ◽  
Prostatic Hyperplasia ◽  
Pharmacological Properties ◽  
Therapeutic Action ◽  
High Biological Activity ◽  
Saint Petersburg ◽  
Medical University

The review summarizes the results of 30-year clinical application of the prostatic bioregulatory peptide Prostatilen. The data from experimental studies, testifying for the high biological activity of the drug is shown, the mechanisms of its therapeutic action are described. The review presents the results of clinical studies demonstrating the effectiveness and pathogenetic justification of the prescription of Prostatilen in the treatment of chronic prostatitis, benign prostatic hyperplasia, infectious and inflammatory diseases of the kidneys and urinary bladder, as well as of several other diseases. The experience of Prostatilen application in the urological clinic of First Pavlov Saint Petersburg State Medical University is shown.

scholarly journals The occurrence rate and clinical application of Osteo-line on the femur neck

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Mingchen Zou ◽  
Haotian Wu ◽  
Shuangquan Yao ◽  
Dong Ren ◽  
Song Liu ◽  
...  
Keyword(s):  
Clinical Application ◽  
Visual Inspection ◽  
Occurrence Rate ◽  
Control Group ◽  
Leg Length ◽  
X Ray ◽  
The Third ◽  
Femur Neck ◽  
Medical University ◽  
Experimental Group

Abstract Background This study was done to observe the incidence of Osteo-line on the femur neck and to explore the clinical application of Osteo-line in osteotomy. Methods Eighty-nine adult femur specimens were selected to observe the incidence of Osteo-line on the femur neck. From August 2015 to January 2019, a total of 278 patients who completed unilateral hip arthroplasty at the Third Hospital of Hebei Medical University were retrospectively included. Patients who accepted osteotomy via Osteo-line on the femur neck were defined as the experimental group (n = 139), and patients who accepted osteotomy via traditional method (The femoral distance 1.5 cm above the trochanter was retained for osteotomy by visual inspection.) were defined as the control group (n = 139). According to the postoperative pelvic X-ray, Photoshop was used to evaluate the leg length discrepancy (LLD) by the CFR-T-LT method. Results Among the 89 specimens, the incidence of anterior Osteo-line was 75.28%, and the incidence of posterior Osteo-line was 100%. According to the clinical application results, the incidence of anterior Osteo-line on the femur neck was 80%, and the incidence of posterior Osteo-line was 100%. The Osteo-line was clearer than those on the femoral specimens. Twenty-six cases had LLD greater than 1 cm (9.29%), including 2 cases in the experimental group and 24 cases in the control group. The average postoperative LLD in the experimental group (0.19 ± 0.38 mm) was significantly shorter than in the control group (0.54 ± 0.51 mm)(P = 0.005). Conclusion The incidence of Osteo-line on the femur neck was high, and patients who accepted osteotomy via Osteo-line on the femur neck can achieve shorter postoperative LLD than the control group.

Biochanin A from Chinese Medicine: An Isoflavone with Diverse Pharmacological Properties

2021 ◽  
pp. 1-21
Author(s):  
Jia Yan ◽  
Panda Qiu ◽  
Xinyu Zhang ◽  
Yuanyuan Zhang ◽  
Linjing Mi ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Clinical Application ◽  
Trifolium Pratense ◽  
Safety Evaluation ◽  
Therapeutic Use ◽  
Biochanin A ◽  
Drug Candidate ◽  
Pharmacological Properties ◽  
Biological Availability ◽  
Trifolium Pratense L

Biochanin A (BCA) is a dietary isoflavone, isolated from the leaves and stems of Trifolium pratense L and many other herbs of Chinese medicine. Recent findings indicated BCA as a promising drug candidate with diverse bioactive effects. On the purpose of evaluating the possibility of BCA in clinical application, this review is trying to provide a comprehensive summary of the pharmacological actions of BCA. The publications collected from PubMed, ScienceDirect, and Wiley databases were summarized for the last 10 years. Then, the potential therapeutic use of BCA on the treatment of various diseases was discussed according to its pharmacological properties, namely, anticancer, anti-inflammatory, anti-bacterial, anti-diabetic, and anti-obesity effects as well as neuroprotective, hepatoprotective, cardioprotective, and osteoprotective effects. BCA might mainly regulate the MAPK, PI3K, NRF2, and NF-kB pathways, respectively, to exert its bioactive effects. However, the limited definitive targets, poor biological availability, and insufficient safety evaluation might block the clinical application of BCA. This review may provide new insights for the development of BCA in the application of related diseases.

scholarly journals Σύνθεση και μελέτη αναστολέων λιπολυτικών ενζύμων

2016 ◽  
Author(s):  
Αικατερίνη Νικολάου
Keyword(s):  
Fatty Acids ◽  
Lysophosphatidic Acid ◽  
Inhibitory Activity ◽  
Functional Group ◽  
Inflammatory Diseases ◽  
Hydroxamic Acids ◽  
Pharmacological Properties ◽  
Ester Bond ◽  
Phospholipases A2 ◽  
Inflammatory Conditions

Phospholipases A2 (PLA2) are enzymes that hydrolyze the sn-2 ester bond of phospholipids releasing free fatty acids and lysophospholipids. Among them, arachidonic acid can be converted into a variety of eicosanoids by metabolic enzymes, while lysophosphatidylcholine (LPC), the most abundant lysophospholipid in plasma and tissues, can be converted into lysophosphatidic acid (LPA) by a secreted enzyme that exhibits lysophospholipase D activity, known as autotaxin (ATX). Both enzymes are involved in inflammatory conditions and, as a consequence, constitute attractive targets for the development of novel agents for the treatment of inflammatory diseases. Due to the fact that molecules which bear the 2-oxoamide functional group and long aliphatic chains exhibit inhibitory activity against cytosolic GIVA cPLA2, 2-oxoamideswith reduced lipophilicity were designed and synthesized. Taking into consideration that in recent years hydroxamic acids have attracted considerable attention due to their pharmacological properties, hydroxamic acids and derivatives there of were designed and synthesized, so as to evaluate their inhibitory activity against ATX.

scholarly journals Biological activity and mechanisms of therapeutic action of rosmarinic acid, luteolin and its sulphated derivatives

2016 ◽  
Vol 62 (1) ◽  
pp. 22-30 ◽  
Author(s):  
A.M. Popov ◽  
O.N. Krivoshapko ◽  
A.A. Klimovich ◽  
A.A. Artyukov
Keyword(s):  
Type 2 Diabetes ◽  
Biological Activity ◽  
Lipid Metabolism ◽  
Phenolic Compounds ◽  
Rosmarinic Acid ◽  
Therapeutic Potential ◽  
Experimental Studies ◽  
Therapeutic Action ◽  
Carbohydrate And Lipid Metabolism

The review considers recent experimental studies of biological activity and mechanisms of therapeutic action of rosmarinic acid, luteolin and its sulfated derivatives in diseases associated with disorders of carbohydrate and lipid metabolism. Particular attention is focused on the results of studies showing a high therapeutic potential of these phenolic compounds in their prophylactic and therapeutic use at experimental modeling of type 2 diabetes and hyperlipidemia. Based on the analysis of our results and the literature data putative mechanisms of therapeutic action of rosmarinic acid, luteolin and its sulfated derivatives have been proposed.

scholarly journals The effect of testosterone on the rate of oxygen consumption by prostate tissue

2018 ◽  
Vol 99 (5) ◽  
pp. 775-778
Author(s):  
A O Lobkarev ◽  
R Kh Khafiz’yanova ◽  
O A Lobkarev
Keyword(s):  
Oxygen Consumption ◽  
Chronic Prostatitis ◽  
Clinical Effectiveness ◽  
Prostatic Hyperplasia ◽  
Prostate Tissue ◽  
Male Rats ◽  
Rate Of Oxygen Consumption ◽  
Testosterone Administration ◽  
Air Tightness ◽  
Increasing Demand

Aim. To study the effect of testosterone on the rate of oxygen consumption by rodent prostate homogenate. Methods. The study included 30 healthy old white outbred male rats divided into two groups with 15 animals in each group. The rats of the first group were administered the application of 1 % testosterone-containing gel Androgel before the operation. The rats of the second group received no testosterone. Under anesthesia prostatectomy was performed. Homogenate was immediately prepared from each prostate. Further every homogenate was placed into 250 ml vial to determine the rate of oxygen consumption. Then the device measuring the concentration of oxygen dissolved in water was placed into the vial, and the air-tightness was created. Each vial was put into the thermostat for 30 minutes at 36.6 ˚C. Then the measurement of the concentration of O2 dissolved in the water was performed. Results. Application of transdermal gel with 1 % testosterone was found to cause increase of oxygen consumption by prostate tissue. This fact can explain why the clinical effectiveness of testosterone is individual to each patient with benign prostatic hyperplasia (BPH) and chronic prostatitis (CP): oxygen supply to the prostate is different in each patient with BPH and CP. So not in every patient the oxygen-transporting system is capable of supplying prostate tissues with the amount of oxygen according to increasing demand of the organ on testosterone administration. Conclusion. Testosterone increases the rate of oxygen consumption by prostate tissue.

Sas enterprise guide 6.1: independent groups comparison for nominal data

2020 ◽  
Vol 20 (3) ◽  
pp. 89-98
Author(s):  
N. S. Bunenkov ◽  
G. F. Bunenkova ◽  
V. V. Komok ◽  
O. A. Grinenko ◽  
A S. Nemkov
Keyword(s):  
Myocardial Infarction ◽  
Clinical Trial ◽  
Data Analysis ◽  
Randomized Clinical Trial ◽  
Postoperative Bleeding ◽  
Nominal Data ◽  
Saint Petersburg ◽  
Develop Algorithm ◽  
Chi Squared ◽  
Medical University

Objective:to develop algorithm of independent groups comparison for nominal data of prospective non-randomized clinical trial AMIRI CABG (ClinicalTrials.gov Identifier: NCT03050489) using SAS Enterprise Guide 6.1. Materials and methods.Data collection was performed according to prospective non-randomized clinical trial AMIRI CABG in Pavlov First St. Petersburg State Medical University, Saint Petersburg, Russia between 2016-2019years with 336 patients. Patients were allocated into three groups of treatment. There is database which include following information: gender, myocardial infarction, stroke and postoperative bleeding. Comparison for nominal data (gender and incidence of myocardial infarction, stroke and bleeding) were calculated with SAS Enterprise Guide6.1 software with Chi-squared test and exact Fisher test. Results.There was developed algorithm of two independent groups comparison for nominal data. Conclusion.Presented algorithm of data analysis allows to compare independent groups for nominal data.

Sign in / Sign up

Export Citation Format

Share Document